The Medtronic Minimed 770G will be added to the Federal Governments Insulin Pump Program – a significant step toward achieving our goal of more technology for more people through our policy agenda. So, what does this mean for you?
Australians living with type 1 diabetes (T1D) are disproportionately affected by a psychological phenomenon called decision fatigue, which hinders their ability to make vital decisions – placing them at greater risk of life-threatening complications such as heart attack and kidney disease.1 People living with T1D must make an extra 180 decisions every day compared to […]
A research breakthrough, funded by JDRF, has shown a promising future for the prevention of type 1 diabetes. Findings from a study by TrialNet show that the immunotherapy drug teplizumab can delay type 1 diabetes diagnosis a median of 2 years in children and adults at high risk. The study showed that teplizumab interferes with […]
First report of its kind in a decade shows the incidence of type 1 diabetes (T1D) in Australia has grown to more than 125,000 people today, with the economic cost now standing at a staggering $2.9 billion per year. The report also highlights the significant financial impact of complications of the disease, with the presence of just two complications increasing the cost to the economy more than fourfold. There is also a serious mental health impact of living with T1D, with patients five times […]
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
A huge thank you to everyone who submitted images and congratulations to our three winners. The Research in Focus competition will return in 2021. We look forward to more incredible entries! Under the Microscope category Winner: The Hardikar Lab at Western Sydney University Title: When human islets have babies (proliferating human islet cells) Caption: A […]
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]
Results from a recently completed JDRF clinical trial have shown some big benefits to hybrid closed-loop technology. Published in the journal Diabetes Care, the results come from a trial led by Prof David O’Neal from the University of Melbourne and the Australian JDRF Closed-Loop Research Group. This study was funded by JDRF through its Type […]
The European Association for the Study of Diabetes (EASD) annual meeting brings together the top researchers from around the world to discuss the latest findings in diabetes research. This year, the meeting took place virtually for the first time, and JDRF researchers from Australia took centre stage to share their exciting results. Here’s our roundup […]
JDRF is pleased to announce the appointment of Prof Maria Craig in a new role as Medical Director of the Australasian Diabetes Data Network (ADDN). Prof Craig has a wealth of experience as a paediatric endocrinologist and clinical researcher, and has worked as a principal investigator on the ADDN project. In her new role as […]
You may have heard that getting a new T1D treatment or device to market can take around 12 to 15 years. This is because there’s a huge amount of work that must take place before that intervention can be approved as being safe for use – from laboratory research in cells, right through to large […]
Every month, we round up the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: An old drug with a […]
This week the federal government has announced $47m in funding over the next four years to accelerate research into preventing, diagnosing and treating Heart Disease and Diabetes. The funding will be delivered through the Targeted Translation Research Accelerator initiative (TTRA), part of the Medical Research Future Fund (MRFF). This is good news for the T1D […]
Recently, we asked you to share any questions you had on type 1 diabetes (T1D), social distancing and beyond for Jane Overland, Co-Author of Straight To The Point: A Guide for Adults Living with Type 1 Diabetes and Diabetes Nurse Practitioner. Turns out, many of you are curious about how coronavirus could affect you as […]
This content was co-written by Simone Collins, Diabetes Social Worker at Canberra Health Services and Melanie Cullen, Paediatric Psychologist and Insulin Pump Program Coordinator at JDRF Australia for families of children newly diagnosed with T1D. The outbreak of COVID-19 has impacted people in all walks of life on an international scale. Our lives have been […]
You may have seen media coverage today based on research in England that looks at the relationship between COVID-19 and both type 1 and type 2 diabetes. JDRF Australia has reviewed both clinical papers this media coverage is based on and has provided summaries of the key findings which can be found here. When reviewing […]
Every month, we round up the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: A new study to understand […]